Instrumentation Laboratory Co. recalls HemosIL ReadiPlasTin 10mL (Part 0020301300) due to potential for inaccurate test results. This affects users of coagulation tests on ACL TOP analyzers.
There is a potential for increased imprecision, out of range quality controls and prolonged sample results.
HemosIL ReadiPlasTin 10mL reagent is being recalled because it may cause inaccurate blood clotting tests. This could lead to incorrect medical decisions if used in coagulation monitoring.
The reagent may produce inconsistent test results, leading to inaccurate measurements of blood clotting time. This could cause incorrect medical decisions for patients on blood thinners.
Users of HemosIL ReadiPlasTin 10mL reagent with ACL TOP analyzers. Patients on oral vitamin K antagonist therapy are most at risk for incorrect test results.
Check for the 10mL size, Part Number 0020301300, and Lot Number N0278177. The product expires February 28, 2019.
Verify the lot number and expiration date on the reagent packaging.
The recall is for potential inaccurate test results, not immediate physical danger.
It could lead to incorrect clotting time measurements, which might affect treatment decisions for blood thinners.
Check the lot number and expiration date; if it matches the recalled product, contact the manufacturer.
We’ve drafted a message you can send HemosIL to request your refund or repair — edit it as you like.
Subject: Recall Z-0077-2019 — HemosIL HemosIL Hello, I own a HemosIL that is covered by recall Z-0077-2019 from HemosIL. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
